Bestphyl-SR-200

Overview

Burgeon Health Series presents the top-quality range of Bestphyl-SR 200, a sustained-release respiratory medication containing  Acebrophylline 200 mg. It is intended to offer sustained bronchodilatory and mucolytic activity, hence improving airway function and respiratory comfort. The sustained-release formulation ensures consistent drug distribution, increased therapeutic efficacy, and higher patient compliance. This medication, Bestphyl-SR 200, comes in 10×10 tablet packaging per strip. All of these essential elements make it an economical and reliable solution for long-term respiratory care.

Uses

• Management of respiratory disorders related to bronchospasm.
• Helps with excessive mucus secretion.
• Promotes easier breathing and enhanced airflow.
• Used in chronic respiratory problems under physician care.

Benefits

• Sustained-release formula for extended action.
• Enhances airway relaxation and mucus clearing.
• Reduces the frequency of doses, increasing patient compliance.
• Consistent and reliable therapeutic performance.
• The price for regular treatment is really economical.